Peer Partners to Improve Physical Activity in Older Latino and Latina Adults With Parkinson's Disease.

November 12, 2025 updated by: Cristina Colón-Semenza, UConn Health

The goal of this interventional study is to culturally adapt and determine feasibility of the peer partner training program and the peer-supported mobile health physical activity intervention in older Latin/Hispanic people with Parkinson's disease.

The main question[s] it aims to answer are:

  • What is the feasibility of the peer partner training program?
  • What is the feasibility of the peer-supported mobile health physical activity intervention?
  • What are the effects of the peer-supported mobile health physical activity intervention on physical activity, motivation, depression, apathy and self-efficacy?

Participants will be asked to:

  • Wear a research-grade activity monitor, Actigraph GT9X device for 10 days at the beginning and end of the study.
  • Watch 11 educational videos about Parkinson´s disease and exercise and attend two virtual educational sessions.
  • Connect with another person with Parkinson´s disease one time a week on a virtual meeting platform for 8 weeks.
  • Use Fitbit activity monitors and connect with other participants through the Fitbit application for 8 weeks.
  • Attend a weekly online exercise class for 8 weeks with other people with Parkinon´s disease.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Connecticut
      • Storrs, Connecticut, United States, 06269
        • University of Connecticut

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Idiopathic Parkinson disease,

  • Able to walk without the assistance of another person for 10 minutes

    -≥ 29 on Telephone Interview for Cognitive Status (TICS)

  • To have a close friend/family member over the age of 18 that would support the participant during the intervention

    -≥ 50 years of age

  • Hispanic
  • To be willing to use an activity monitor and use a Fitbit and Fitbit application
  • To be on a stable course of PD medications without any plans for change over the next 3 months
  • To be able to speak, read and write in Spanish or English

Exclusion Criteria:

  • Unstable cardiopulmonary, orthopedic, psychological or metabolic condition
  • Atypical Parkinsonism Disorders
  • A fall in the last 6 months (that was unrelated to an external force)
  • Currently engaging in 150 minutes of mod-vigorous physical activity/week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Social support for physical activity
Socially supported (peer, family and group) physical activity group.
Behavioral: Socially supported physical activity
Use of a culturally and linguistically tailored intervention that uses mobile health technology plus social support to increase engagement in physical activity in the management of Parkinson´s disease.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability of Intervention Measure (AIM)
Time Frame: After completion of the entire intervention (11 weeks)
A standardized measure of acceptability that indicates percent agreement with acceptability of the intervention ranging from 20-100%. Higher scores indicate agreement (better outcome) with the acceptability of the intervention.
After completion of the entire intervention (11 weeks)
Intervention Appropriateness Measure (IAM)
Time Frame: After completion of the entire intervention (11 weeks)
A standardized measure of appropriateness that indicates percent agreement with appropriateness of the intervention ranging from 20-100%. Higher scores indicate more agreement (better outcome) with the appropriateness of the intervention.
After completion of the entire intervention (11 weeks)
Feasibility of Intervention Measure (FIM)
Time Frame: After completion of the entire intervention (11 weeks)
A standardized measure of feasibility that indicates percent agreement with feasibility of the intervention ranging from 20-100%. Higher scores indicate more agreement (better outcome) with the feasibility of the intervention.
After completion of the entire intervention (11 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective Measurement of Physical Activity
Time Frame: 10 days at baseline and post-intervention (approximately 12 to 14 weeks)
Steps per day measured using a research-grade activity monitor will provide group mean change in physical activity from baseline to post-intervention.
10 days at baseline and post-intervention (approximately 12 to 14 weeks)
Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2)
Time Frame: Baseline and post Intervention (approximately 12 to 14 weeks)
The Behavioral Regulation in Exercise Questionnaire-2, Relative Autonomy Index, is a standardized, 19-item survey that evaluates motivation for exercise. The scores range from -24 to +20 with higher scores indicating increased motivation or better outcomes. The group mean change score is presented.
Baseline and post Intervention (approximately 12 to 14 weeks)
Parkinson's Disease Questionnaire-39 (PDQ-39)
Time Frame: Pre and post intervention (approximately 12 to 14 weeks)
The Parkinson's Disease Questionnaire-39 (PDQ-39) is a 39-item, self-report survey that assess quality of life. The scores range from 0-100 and a decrease indicates an improvement in quality of life. The group mean change total scores will be evaluated.
Pre and post intervention (approximately 12 to 14 weeks)
Geriatric Depression Scale-Short Form
Time Frame: Pre and post intervention (approximately 12 to 14 weeks)
The Geriatric Depression Scale (GDS) -15, is a 15-item self-report measure of depression in older adults. The score ranges from 0-15 with higher scores indicating higher levels of depression (worse outcome). Group mean change scores related to depression are reported.
Pre and post intervention (approximately 12 to 14 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

UConn Health

Collaborators

National Institutes of Health (NIH)
National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Cristina Colón-Semenza, PhD, University of Connecticut

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Actual)

July 1, 2024

Study Completion (Actual)

August 30, 2024

Study Registration Dates

First Submitted

November 10, 2023

First Submitted That Met QC Criteria

December 11, 2023

First Posted (Actual)

December 14, 2023

Study Record Updates

Last Update Posted (Actual)

November 26, 2025

Last Update Submitted That Met QC Criteria

November 12, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 23-117S-2
  • P30AG067988 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Socially supported physical activity

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe